Home » ETF » VIRS

VIRS - Pacer BioThreat Strategy ETF

Stock Price: $30.46 USD 0.17 (0.57%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
After-hours: $30.46 0.00 (0.00%) Apr 21, 8:00 PM
Assets $4.57M
NAV $30.46
Expense Ratio 0.70%
PE Ratio 25.09
Beta (5Y) -0.84
Dividend (ttm) $0.15
Dividend Yield 0.48%
Ex-Dividend Date Mar 22, 2021
1-Year Return -
Trading Day April 21
Last Price $30.46
Previous Close $30.29
Change ($) 0.17
Change (%) 0.57%
Day's Open 30.29
Day's Range 30.28 - 30.46
Day's Volume 1,124
52-Week Range 24.17 - 30.59

Fund Description

The investment seeks to track the performance, before fees and expenses, of the LifeSci BioThreat Strategy Index (the "index"). Under normal circumstances, at least 80% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. It is non-diversified.

Asset Class
Equity
Inception Date
Jun 24, 2020
Exchange
BATS
Ticker Symbol
VIRS
Index Tracked
LifeSci BioThreat Strategy Index

Top 10 Holdings

49.28% of assets
NameSymbolWeight
Home DepotHD5.42%
Abbott LaboratoriesABT5.23%
Johnson & JohnsonJNJ5.06%
NVIDIANVDA4.99%
Lowe'sLOW4.98%
NetflixNFLX4.87%
DanaherDHR4.76%
Thermo Fisher ScientificTMO4.76%
AmazonAMZN4.73%
WalmartWMT4.49%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Mar 22, 2021$0.05936Jan 1, 1970
Dec 21, 2020$0.03944Jan 1, 1970
Sep 21, 2020$0.04845Jan 1, 1970
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart p...

Other tickers mentioned: EDOC, EDUT, GERM, WFH
3 weeks ago - Zacks Investment Research

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, GERM, WFH
3 months ago - Zacks Investment Research

The rest of 2020 and the beginning of 2021 are expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, GERM, WFH
4 months ago - Zacks Investment Research

The remainder of 2020 is expected to continue bearing the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, GERM, WFH
5 months ago - Zacks Investment Research

Both companies have reasonable chances of beating earnings estimates with Netflix witnessing positive earnings estimate revisions. On the other hand, Amazon saw negative earnings estimate revision.

Other tickers mentioned: FDIS, FDN, FNGS, IYC, JHCS, ONLN, PBS ...
6 months ago - Zacks Investment Research

It feels like the rest of 2020 will continue to bear the brunt of the coronavirus outbreak and therefore, a COVID-19-themed ETF could be a smart pick.

Other tickers mentioned: EDOC, EDUT, GERM, WFH
6 months ago - Zacks Investment Research

The news has put the spotlight on some ETFs, which could be the best ways for investors to tap the opportunity arising from the proposed Nvidia deal.

Other tickers mentioned: BOTZ, SMH, SOXX, ESPO
7 months ago - Zacks Investment Research

News broke Saturday that semiconductor giant Nvidia (NASDAQ: NVDA) is in talks to acquire Arm Holdings, a UK-based chip designer, from Japan's SoftBank Group for $40 billion.

Other tickers mentioned: BOTZ, SMH
7 months ago - Benzinga

There are advantages -- and disadvantages -- to some of the newest ETFs on the market.

Other tickers mentioned: GERM, WFH
7 months ago - The Motley Fool

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

Other tickers mentioned: EDOC, EDUT, GERM
7 months ago - Zacks Investment Research

The Pacer BioThreat Strategy ETF (VIRS) is an outperforming healthcare sector-related exchange traded fund that has benefited from exposure to areas outside of the healthcare solutions category. Over th...

7 months ago - ETF Trends

In the current scenario of the rising work-from-home and online shopping trends, online learning, home entertainment, telemedicine and digital health services are slowly becoming the "new normal."

Other tickers mentioned: EDOC, EDUT, GERM
7 months ago - Zacks Investment Research

Should You Invest in COVID Themed ETFs?

YouTube video

We highlight three new ETFs that seek to capitalize on coronavirus.

Other tickers mentioned: GERM, WFH
8 months ago - Zacks Investment Research

While Netflix beat revenue estimates and reported solid subscriber addition, it missed the earnings estimate and offered weak third-quarter subscriber guidance.

Other tickers mentioned: ENTR, FNGS, JHCS, PBS
9 months ago - Zacks Investment Research

The outperformance for Netflix is expected to continue given that the company has strong chances of beating estimates for the second quarter and witnessed positive earnings estimate revisions.

Other tickers mentioned: ENTR, FNGS, JHCS, PBS
9 months ago - Zacks Investment Research

Solid demand for graphics chips in data centers, Mellanox deal, presence in the video gaming as well as automotive car industries should boost Nvidia-heavy ETFs.

Other tickers mentioned: BOTZ, BOUT, ESPO, FNGS, HERO, SMH
9 months ago - Zacks Investment Research

There are a handful of new ETFs on the market today that are spins on the novel coronavirus, with the VIRS ETF currently as the most diverse.

9 months ago - InvestorPlace

Overall, the S&P 500 is down 1.6% this year (as of Jul 6, 2020) while the Nasdaq Composite has gained 16.3% in the year-to-date frame. The Dow Jones has suffered the most with 7.9% year-to-date loss.

Other tickers mentioned: CRAK, GDXJ, GERM, GOEX, IBUY, JKE, MGK ...
9 months ago - Zacks Investment Research

It was just a week ago that the first exchange-traded fund dedicated to vaccine developers, plenty engaged in the fight against the coronavirus, came to market.

9 months ago - Benzinga